drugset / Trial / NCT05879146
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
NaSingle-groupOpen-labelTreatment
Summary
To learn about the safety and effects of an investigational drug called nirogacestat when given to participants with a desmoid tumor/aggressive fibromatosis
Timeline
- Start
- 2024-11-26
- Primary completion
- 2027-01-31
- Completion
- 2028-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nirogacestat | Small molecule | 100 mg | Oral |
| Subject | Nirogacestat | Small molecule | 150 mg | Oral |